Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Brian Baranick

Brian Baranick

General Manager, Precision Oncology

Joined Exact Sciences: 2020

Brian Baranick serves as our General Manager, Precision Oncology. He previously served as Senior Vice President Strategy and Business Development since February 2021 and Vice President, Strategy & Internal Consulting. Prior to joining Exact Sciences, Mr. Baranick was with L.E.K. Consulting, LLC., where he was a Partner and Managing Director focused on growing the diagnostics and life science tools segment of L.E.K.’s healthcare vertical. Mr. Baranick holds a Ph.D. in Molecular Biology from the University of California Los Angeles.